AMLUM Trademark

Trademark Overview

On Thursday, June 24, 2010, a trademark application was filed for AMLUM with the United States Patent and Trademark Office. The USPTO has given the AMLUM trademark a serial number of 85070493. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 27, 2014. This trademark is owned by Glaxo Group Limited. The AMLUM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
amlum

General Information

Serial Number85070493
Word MarkAMLUM
Filing DateThursday, June 24, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 27, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 26, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 29, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, January 27, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 27, 2014ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 18, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 17, 2013EXTENSION 5 GRANTED
Tuesday, June 11, 2013EXTENSION 5 FILED
Tuesday, June 11, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 5, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 4, 2012EXTENSION 4 GRANTED
Monday, December 3, 2012EXTENSION 4 FILED
Monday, December 3, 2012TEAS EXTENSION RECEIVED
Friday, June 15, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 14, 2012EXTENSION 3 GRANTED
Wednesday, June 13, 2012EXTENSION 3 FILED
Wednesday, June 13, 2012TEAS EXTENSION RECEIVED
Tuesday, December 13, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 12, 2011EXTENSION 2 GRANTED
Friday, December 2, 2011EXTENSION 2 FILED
Monday, December 12, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 1, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 2, 2011TEAS EXTENSION RECEIVED
Wednesday, June 15, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 13, 2011EXTENSION 1 GRANTED
Monday, June 13, 2011EXTENSION 1 FILED
Monday, June 13, 2011TEAS EXTENSION RECEIVED
Tuesday, December 21, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 26, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 26, 2010PUBLISHED FOR OPPOSITION
Tuesday, September 21, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 21, 2010ASSIGNED TO LIE
Monday, September 13, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 13, 2010ASSIGNED TO EXAMINER
Tuesday, June 29, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 28, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

amlum pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic